Trials / Completed
CompletedNCT02028663
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
A Double-Blind, Randomized, Dose-finding Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 206 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the optimal dose and administration methods of CJ-12420 in patients with erosive esophagitis by comparing the safety and efficacy of orally administered CJ-12420 to esomeprazole 40mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CJ-12420 | Once daily, Oral administration |
| DRUG | Esomeprazole | Once daily, Oral administration |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-01-07
- Last updated
- 2014-08-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02028663. Inclusion in this directory is not an endorsement.